2.81
Precedente Chiudi:
$2.73
Aprire:
$2.73
Volume 24 ore:
1.28M
Relative Volume:
0.87
Capitalizzazione di mercato:
$1.05B
Reddito:
$159.54M
Utile/perdita netta:
$5.06M
Rapporto P/E:
-638.64
EPS:
-0.0044
Flusso di cassa netto:
$26.19M
1 W Prestazione:
+3.69%
1M Prestazione:
+2.93%
6M Prestazione:
+5.64%
1 anno Prestazione:
+47.12%
Cronos Group Inc Stock (CRON) Company Profile
Nome
Cronos Group Inc
Settore
Telefono
(416) 504-0004
Indirizzo
4491 CONCESSION RD 12, STAYNER, ON
Compare CRON vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CRON
Cronos Group Inc
|
2.81 | 1.05B | 159.54M | 5.06M | 26.19M | -0.0044 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.91 | 50.27B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
9.24 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.21 | 38.67B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
ZTS
Zoetis Inc
|
76.09 | 31.90B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
542.66 | 23.03B | 3.17B | 1.29B | 1.01B | 27.09 |
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Iniziato | Canaccord Genuity | Buy |
| 2022-11-02 | Iniziato | Bernstein | Mkt Perform |
| 2022-07-28 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2022-05-11 | Aggiornamento | CIBC | Neutral → Sector Outperform |
| 2022-03-22 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-27 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-11-18 | Ripresa | BofA Securities | Underperform |
| 2021-04-28 | Ripresa | BofA Securities | Underperform |
| 2021-02-22 | Downgrade | CIBC | Sector Outperform → Neutral |
| 2020-06-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-27 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-14 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-04-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-03-31 | Downgrade | Canaccord Genuity | Hold → Sell |
| 2020-03-04 | Aggiornamento | MKM Partners | Neutral → Buy |
| 2020-03-03 | Downgrade | Stifel | Buy → Hold |
| 2019-10-18 | Aggiornamento | Stifel | Hold → Buy |
| 2019-09-20 | Iniziato | MKM Partners | Neutral |
| 2019-09-05 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2019-08-13 | Iniziato | Piper Jaffray | Overweight |
| 2019-08-09 | Aggiornamento | Canaccord Genuity | Sell → Hold |
| 2019-06-28 | Iniziato | Consumer Edge Research | Equal Weight |
| 2019-06-06 | Iniziato | Stifel | Hold |
| 2019-06-05 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2019-04-17 | Iniziato | BofA/Merrill | Underperform |
| 2019-03-27 | Downgrade | Canaccord Genuity | Hold → Sell |
| 2019-02-25 | Iniziato | Jefferies | Underperform |
| 2019-01-18 | Iniziato | CIBC | Sector Outperform |
Mostra tutto
Cronos Group Inc Borsa (CRON) Ultime notizie
Price to earnings forward of Cronos Group Inc – TSX:CRON - TradingView
Cronos Group Inc. stock rises Friday, outperforms market - MarketWatch
CRON strengthens global footprint: Is the cannabis stock worth buying? - MSN
Cronos Group Inc Actuals & Estimates (TSX:CRON) - TradingView
Cronos Group Inc Actuals & Estimates (FWB:7CI) - TradingView
7CI Forecast — Price Target — Prediction for 2027 - TradingView
CRON Forecast — Price Target — Prediction for 2027 - TradingView
Cronos Group Inc Actuals & Estimates (NEO:CRON) - TradingView
CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying? - Yahoo Finance
Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders - Sahm
Cronos Shareholders Approve Directors, Say-on-Pay and Auditor - The Globe and Mail
Cronos Group Inc. stock rises Tuesday, outperforms market - MarketWatch
Cronos Group Inc (CRON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cronos Group shareholders approve board slate and auditor at annual meeting By Investing.com - Investing.com Australia
Form 8K CRONOS GROUP INC. For: 22 June By Investing.com - Investing.com India
Cronos Group Inc. (CRON) Announces 2026 Annual Meeting Results and Key SEC Filing Details - Minichart
Cronos Group shareholders approve board slate and auditor at annual meeting - Investing.com
Cronos Group shareholders re-elect directors and approve executive pay at 2026 annual meeting - Pluang
Cronos Group shareholders back board, pay vote and auditor - Stock Titan
Cronos Group Inc. stock falls Monday, underperforms market - MarketWatch
Cronos Group (NASDAQ: CRON) holders back pay and auditor at 2026 meeting - Stock Titan
Cronos Group (CRON) price target increased by 10.71% to 3.79 - MSN
Cronos Group StockAnalyst views and long-term cannabis strategy - Ad-hoc-news.de
Why Is Cronos Group Inc. (TSX:CRON) Rising After Buyback in S&P/TSX Composite Index? - Kalkine Media
Should Cronos Group’s Expanded US$50 Million Buyback Shape Capital Allocation Views For Cronos (TSX:CRON) Investors? - Yahoo Finance
Cronos Group Inc (CRON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cronos Group Inc. stock rises Thursday, still underperforms market - MarketWatch
CRON: All agenda items, including director elections and auditor appointment, were approved without dissent - TradingView
Cronos Group Inc (CRON) Institutional Confidence - TradingKey
Cronos Extends Share Repurchase Program to Toronto Stock Exchange - Moomoo
Cronos Group Inc (CRON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cronos Group Inc (CRON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cronos Group Inc (CRON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cronos Group Inc (CRON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cronos Group Inc (CRON) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cronos Group Inc (CRON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cronos Group files to expand share buyback to TSX By Investing.com - Investing.com India
Cronos Group Inc. stock outperforms market despite losses on the day - MarketWatch
Cronos Group files to expand share buyback to TSX - Investing.com
Cronos Announces Extension of Share Repurchase Program to the Toronto Stock Exchange - GlobeNewswire
Cronos extends share buyback program to Toronto Stock Exchange until June 2026. - Pluang
Cronos Group Inc. stock falls Friday, underperforms market - MarketWatch
Spinach® is the Number One Vape Brand in Canada - GlobeNewswire
Canada's top cannabis vape brand adds 'liquid diamond' flavors - Stock Titan
Cronos Group Inc. stock falls Wednesday, still outperforms market - MarketWatch
Cronos Group Inc (NASDAQ:CRON) Passes Minervini Trend Template and High Growth Momentum Screen - ChartMill
Cronos Group Inc. stock rises Monday, outperforms market - MarketWatch
Cronos Group sells entire stake in medical marijuana company - Digital Journal
Cronos Group Inc. stock falls Friday, still outperforms market - MarketWatch
Cronos Group Inc stock (CA22717L1013): cannabis share edges lower amid sector weakness - AD HOC NEWS
Cronos Group Inc. stock rises Thursday, outperforms market - MarketWatch
Cronos Group Inc Azioni (CRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):